Medifron DBT Co. Ltd (065650) — Financial Flexibility Index
Medifron DBT Co. Ltd (065650) has a Financial Flexibility Index of -0.14x as of September 2025. Free cash flow of ₩-12.54 Billion (operating CF ₩-12.73 Billion minus capex ₩198.12 Million) represents 0% of total liabilities (₩86.61 Billion). Also explore Medifron DBT Co. Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medifron DBT Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Medifron DBT Co. Ltd across 11 annual periods. Check 065650 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Medifron DBT Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Medifron DBT Co. Ltd. For the full company profile including market capitalisation, see Medifron DBT Co. Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | ₩-1.94 Billion | ₩-4.54 Billion | ₩42.92 Billion | ▲ +52.2% |
| 2023 | -0.09x | ₩-1.79 Billion | ₩-2.14 Billion | ₩18.89 Billion | ▼ -46.9% |
| 2022 | -0.06x | ₩-1.59 Billion | ₩-2.91 Billion | ₩24.66 Billion | ▼ -127.0% |
| 2021 | 0.24x | ₩1.62 Billion | ₩-1.50 Billion | ₩6.81 Billion | ▲ +628.7% |
| 2020 | -0.05x | ₩-874.06 Million | ₩-1.67 Billion | ₩19.36 Billion | ▲ +98.1% |
| 2019 | -2.39x | ₩-4.23 Billion | ₩-4.28 Billion | ₩1.77 Billion | ▼ -580.5% |
| 2018 | -0.35x | ₩-832.97 Million | ₩-852.48 Million | ₩2.37 Billion | ▲ +54.5% |
| 2017 | -0.77x | ₩-1.15 Billion | ₩-1.17 Billion | ₩1.49 Billion | ▼ -49.2% |
| 2016 | -0.52x | ₩-1.13 Billion | ₩-1.15 Billion | ₩2.18 Billion | ▼ -2436.0% |
| 2015 | -0.02x | ₩-143.36 Million | ₩-170.27 Million | ₩7.04 Billion | ▼ -213.6% |
| 2014 | 0.02x | ₩27.61 Million | ₩701.96K | ₩1.54 Billion | — |